Viewing Study NCT02573220


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-02-24 @ 2:31 PM
Study NCT ID: NCT02573220
Status: WITHDRAWN
Last Update Posted: 2016-12-09
First Post: 2015-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer
Sponsor:
Organization: